Survival of Patients with Deficient Mismatch Repair Versus Proficient Mismatch Repair Metastatic Colorectal Cancer Receiving Curative-Intent Local Treatment of Metastases in a Nationwide Cohort.
Journal Information
Full Title: Ann Surg Oncol
Abbreviation: Ann Surg Oncol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: General Surgery
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosures C.J.P.: Nordic Pharma. E.W.: None. F.v.d.B.: None. G.V.: BMS, Merck, Servier, Personal Genome Diagnostics, Bayer, Sirtex, Pierre Fabre, Lilly. I.d.H.: ROCHE, RanD Biotech. J.H.: None. J.R.: Bayer, BMS, Merck-Serono, Pierre Fabre, Servier, HUB4organoids, Cleara Biotech. K.B.: None. K.Z.: None. M.K.: Nordic Farma, Merck-Serono, Pierre Fabre, Servier, Bayer, Bristol Myers Squibb, Merck, Roche and Servier. M.L.: None. W.v.G.: None."
"Funding No funder or sponsor was involved in this study."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025